Nuria Maroto

499 total citations
19 papers, 210 citations indexed

About

Nuria Maroto is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Nuria Maroto has authored 19 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 11 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Nuria Maroto's work include Inflammatory Bowel Disease (14 papers), Microscopic Colitis (10 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Nuria Maroto is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Microscopic Colitis (10 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Nuria Maroto collaborates with scholars based in Spain, Italy and Israel. Nuria Maroto's co-authors include Marta Ponce, Vicente Garrigues, Marta Maia Boscá-Watts, Julio Ponce, Marco Bustamante, Vicente Ortiz, Daniel Carpio, M Rojas-Feria, Carme Loras and Ignacio Marín‐Jiménez and has published in prestigious journals such as Gastroenterology, World Journal of Gastroenterology and Digestive Diseases and Sciences.

In The Last Decade

Nuria Maroto

19 papers receiving 206 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuria Maroto Spain 7 130 124 90 54 28 19 210
Ari Silbermintz Israel 11 144 1.1× 148 1.2× 166 1.8× 106 2.0× 17 0.6× 29 278
Tommy Holmström Sweden 8 266 2.0× 257 2.1× 128 1.4× 34 0.6× 13 0.5× 11 331
P Bonnière France 5 85 0.7× 94 0.8× 110 1.2× 52 1.0× 35 1.3× 8 235
Emmanuel Archavlis Greece 7 246 1.9× 218 1.8× 173 1.9× 53 1.0× 18 0.6× 19 340
Federico Gómez-Camacho Spain 6 195 1.5× 188 1.5× 134 1.5× 39 0.7× 69 2.5× 9 310
Gavin Barr Australia 9 206 1.6× 177 1.4× 155 1.7× 60 1.1× 14 0.5× 15 315
Anders Forss Sweden 8 141 1.1× 138 1.1× 78 0.9× 28 0.5× 21 0.8× 33 196
Luca Ferraris Italy 5 163 1.3× 128 1.0× 74 0.8× 34 0.6× 32 1.1× 10 213
Juan E. Naves Spain 9 103 0.8× 97 0.8× 75 0.8× 14 0.3× 22 0.8× 17 198
Fabián Juliao Baños Colombia 5 164 1.3× 130 1.0× 81 0.9× 20 0.4× 19 0.7× 38 209

Countries citing papers authored by Nuria Maroto

Since Specialization
Citations

This map shows the geographic impact of Nuria Maroto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuria Maroto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuria Maroto more than expected).

Fields of papers citing papers by Nuria Maroto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuria Maroto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuria Maroto. The network helps show where Nuria Maroto may publish in the future.

Co-authorship network of co-authors of Nuria Maroto

This figure shows the co-authorship network connecting the top 25 collaborators of Nuria Maroto. A scholar is included among the top collaborators of Nuria Maroto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuria Maroto. Nuria Maroto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Huguet, José María, Xavier Cortés, Marta Maia Boscá-Watts, et al.. (2022). Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia. Journal of Clinical Medicine. 11(10). 2786–2786. 5 indexed citations
2.
Huguet, José María, et al.. (2021). Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease. World Journal of Clinical Cases. 9(36). 11285–11299. 4 indexed citations
3.
Boscá-Watts, Marta Maia, Rafael Alós, Nuria Maroto, et al.. (2020). Recommendations of the Crohn’s Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn’s disease. Gastroenterología y Hepatología (English Edition). 43(3). 155–168. 8 indexed citations
4.
Boscá-Watts, Marta Maia, Rafael Alós, Nuria Maroto, et al.. (2019). Recomendaciones del Grupo Español de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) para el tratamiento de las fístulas perianales de la enfermedad de Crohn. Gastroenterología y Hepatología. 43(3). 155–168. 11 indexed citations
5.
Hinojosa, Esther, et al.. (2019). Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease. Revista Española de Enfermedades Digestivas. 111(6). 431–436. 1 indexed citations
6.
Iborra, Marisa, Belén Beltrán, Nuria Maroto, et al.. (2018). Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents. Gastroenterología y Hepatología (English Edition). 41(9). 535–543. 1 indexed citations
7.
Iborra, Marisa, Belén Beltrán, Nuria Maroto, et al.. (2018). Vedolizumab, una opción en pacientes con enfermedad inflamatoria intestinal intolerantes a tiopurinas y refractarios a biológicos. Gastroenterología y Hepatología. 41(9). 535–543. 3 indexed citations
8.
Iborra, Marisa, Nuria Maroto, Pablo Navarro, et al.. (2018). P714 Vedolizumab, an adequate option in medically refractory and thiopurine-intolerant inflammatory bowel disease patients. Journal of Crohn s and Colitis. 12(supplement_1). S472–S473. 2 indexed citations
9.
Huguet, José María, Marisa Iborra, Marta Maia Boscá-Watts, et al.. (2018). Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior?. Scandinavian Journal of Gastroenterology. 53(9). 1079–1084. 6 indexed citations
10.
Boscá-Watts, Marta Maia, Xavier Cortés, Marisa Iborra, et al.. (2016). Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study. World Journal of Gastroenterology. 22(47). 10432–10432. 25 indexed citations
11.
12.
García‐Bosch, Orlando, Míriam Mañosa, Valle García-Sánchez, et al.. (2011). Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study. Inflammatory Bowel Diseases. 18(5). 812–817. 69 indexed citations
13.
Acosta, Manuel Barreiro‐de, Orlando García‐Bosch, Míriam Mañosa, et al.. (2011). Efficacy of Infliximab Rescue Therapy in Patients With Chronic Refractory Pouchitis: A Multicenter Study. Gastroenterology. 140(5). S–591. 2 indexed citations
14.
López‐Serrano, Antonio, et al.. (2010). A new guidewire cannulation technique in ERCP: successful deep biliary access with triple-lumen sphincterotome and guidewire controlled by the endoscopist. Surgical Endoscopy. 25(6). 1876–1882. 5 indexed citations
15.
Ponce, Julio, Vicente Ortiz, Nuria Maroto, et al.. (2010). High Prevalence of Heartburn and Low Acid Sensitivity in Patients with Idiopathic Achalasia. Digestive Diseases and Sciences. 56(3). 773–776. 29 indexed citations
16.
Primo, J, et al.. (2010). Incidence of adult form of autoimmune hepatitis in Valencia (Spain).. PubMed. 72(4). 402–6. 24 indexed citations
17.
Hinojosa, Joaquín, et al.. (2008). Severe Myalgia Associated with Adalimumab Treatment in a Patient with Crohn's Disease. Annals of Pharmacotherapy. 42(7-8). 1130–1133. 2 indexed citations
18.
Nos, Pilar, Vicente Garrigues, Guillermo Bastida, et al.. (2004). Outcome of Patients with Nonstenotic, Nonfistulizing Crohn’s Disease. Digestive Diseases and Sciences. 49(11-12). 1771–1776. 9 indexed citations
19.
Maroto, Nuria & Marta Ponce. (2003). Tuberculosis y aparato digestivo. Gastroenterología y Hepatología. 26(1). 34–41. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ari Silbermintz Breakdown of academic impact, for papers by Tommy Holmström Breakdown of academic impact, for papers by P Bonnière Breakdown of academic impact, for papers by Emmanuel Archavlis Breakdown of academic impact, for papers by Federico Gómez-Camacho Breakdown of academic impact, for papers by Gavin Barr Breakdown of academic impact, for papers by Anders Forss Breakdown of academic impact, for papers by Luca Ferraris Breakdown of academic impact, for papers by Juan E. Naves Breakdown of academic impact, for papers by Fabián Juliao Baños
Rankless by CCL
2026